Looking for more Scientific Resources

The William Guy Forbeck Research Foundation is working with the scientific community to shortening the cancer research timetable.

Annual Forum 2015 – Immunotherapy

January 13, 2015

Dr.Catherine Bollard, Washington Children’s Hospital, Washington, DC Dr. Daniel Powell, University of Pennsylvania, Philadelphia, PA   Immunotherapy  Some of the most exciting results in cancer medicine, in the last decade, have come about by treating relapsed patients with B cell lymphoma with their own T cells that have been modified to attack the tumor cells.

Annual Forum 2014 – Invasion & Metastasis

February 21, 2014

2014 – Invasion and Metastasis   November 6 – 9th, 2014 Ann Chambers, PhD, University of Western Ontario, London, ON Canada Zena Werb, PhD, University of California, San Francisco, CA   Most cancer deaths are due to metastasis – the spread of cancer from its site of origin to distant, vital organs, and the physiological

Annual Forum 2013 – Resistance Mechanisms

December 1, 2013

CHAIRMEN Joan Brugge, Harvard Medical School, Boston MA Jeffrey Engelman, Massachusetts General Hospital, Boston, MA PARTICIPANTS Alberto Bardelli, PhD, University of Torino, Candiolo, Italy Jose Baselgaj, Memorial Sloan-Kettering Cancer Institute, New York, NY Bruce A. Chabner, MD, Massachusetts General Hospital, Boston, MA Dr. William Dalton, Moffitt Caner Center & Research Institute, Tampa, FL Jeffrey Engelman,

Annual Forum 2012 – Tumor Metabolism

December 1, 2012

January 30, 2012 The William Guy Forbeck Research Foundation:  Annual Forum 2012 – Summary  Tumor Metabolism  Co-Chairs:  Lewis C. Cantley, PhD., Beth Israel Deaconess Medical Center, Boston, MA and Eileen White, PhD., The Cancer Institute of New Jersey, New Brunswick, NJ.  Participants:  John Blenis, PhD., Harvard Medical School, Boston, MA; Heather Christofk, PhD, UCLA, Los

Annual Forum 2011 – Epigenetics & Drug Therapy

January 30, 2011

The William Guy Forbeck Research Foundation:  Annual Forum 2011 – Summary  Epigenetics & Drug Therapy  Co-Chairs:  Scott A. Armstrong, MD, Ph.D., Dana Farber Cancer Institute, Boston, MA  Steven Henrikoff, Ph.D., Fred Hutchinson Cancer Research Center, Seattle, WA  Participants  Bruno Amati, Ph.D., Istituto Italiano di Tecnologia (IIT) at the IFOM-IEO Campus Center for Genomic Science of